Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 2020 Elections: Impact and Legislative Update

    Contains 2 Component(s) Includes a Live Web Event on 12/09/2020 at 2:00 PM (EST)

    After the election

    While the healthcare community continues to analyze the impact of the elections, policymakers are already balancing new priorities with the ongoing pandemic response. Join Ben Jones, Vice President of Government Relations & Public Policy, McKesson Specialty Health & The US Oncology Network, for a look at what’s to come following the November elections; how they will shape cancer care delivery in 2021 and beyond; and how public policy will directly impact oncology providers and patients.

    Ben Jones

    Vice President of Government Affairs and Public Policy

    Ben Jones currently serves as Vice President of Government Relations & Public Policy for the McKesson specialty provider organization and The US Oncology Network.  In this role, Ben leads the federal and state advocacy efforts around access to care in the community as well as adequate and fair physician reimbursement. Ben has been in this role for over 12 years and serves as the Executive Director of The US Oncology Network political action committee (PAC). Prior to joining McKesson, Ben spent many years in public policy at the state and federal level, including 5 years with the former U.S. House Majority Leader.

    Ben graduated from the University of Houston with a degree in political science and currently lives in The Woodlands, TX.

    Ahad Sadiq, MD (Moderator)

    Medical Oncologist, Fort Wayne Medical Oncology & Hematology, Inc.

    Ahad Sadiq, MD, is board certified in internal medicine, hematology, and oncology, and has a special interest in thoracic oncology. He leads several clinical trials in thoracic oncology at Fort Wayne Medical Oncology and Hematology—focusing on the benefit of using immunotherapies.

  • 2020 Oncology Reimbursement Meeting

    Contains 18 Component(s), Includes Credits Includes a Live Web Event on 12/11/2020 at 2:45 PM (EST)

    A series of sessions designed to strengthen your program’s operations, accelerate your knowledge in oncology business, and take on this rapidly changing healthcare landscape.

    imageAt the ACCC Oncology Reimbursement Meeting, we can equip you and your colleagues with the tools needed to strengthen your program’s operations, accelerate your knowledge in oncology business, and take on this rapidly changing healthcare landscape.
    In this series of sessions, you'll have the opportunity to:
            • Review the latest trends in oncology coding and billing based on the 2020 Medicare Final Rules
            • Assess financial strategies to track and improve the financial health of your cancer program
            • Gain insight to upcoming coding and reimbursement challenges related to financial counseling, compliance, and authorizations in medical and radiation oncology
            • Identify opportunities to improve the financial navigation services at your practice or program
    image

    Billers and Coders: Each session in this program has the prior approval from the American Academy of Professional Coders (AAPC) for 1.0 continuing education hour. Granting of prior approval in no way constitutes endorsement by AAPC of the program content or the program sponsor.

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the sessions.

    Ricky Newton, CPA

    Chief Financial and Operating Officer, Cancer Specialists of Tidewater, Ltd.

    Ricky Newton has over 28 years of experience in the healthcare industry. He currently serves as Director of Financial Services and Operations for the Community Oncology Alliance. Since 1997 he has been the administrator for Cancer Specialists of Tidewater, Ltd. He worked for Riverside Health Systems from July 2007 to July 2014 serving as their director for oncology operations. Prior to joining the practice he was a CPA with the public accounting firm of Failes & Associates. 

    Ricky has presented and consulted at over 350 conferences and practices in 46 states on topics such as financial and practice management issues in medical practices, health care law, relationships between oncologists and hospitals, managing employees, contracting with insurers, pharmacy management including managing pharmaceutical contracts, compensation models as well as other topics in the operating an oncology practice. 

    Currently, Ricky serves as treasurer of the Virginia Association of Hematology and Oncology Managers (VAHOM), Virginia Association of Hematologists and Oncologist (VAHO), Southeastern Coalition of Oncology Practitioner (SCOOP), National Oncology Society Network (NOSN) and Community Oncology Alliance (COA). 

    Ricky graduated with honors in 1990 from Old Dominion University with majors in Accounting and Finance.

    Teri Bedard, BA, RT(R)(T), CPC

    Director, Client Services, Revenue Cycle Coding Strategies

    Teri Bedard is the Executive Director, Client & Corporate Resources with Revenue Cycle Coding Strategies, LLC.  Her expertise includes over 20 years of medical experience.  Teri has served as a senior and Staff Radiation Therapist at renowned oncology practices across the Midwest and during her tenure with RCCS, has served as a Senior Consultant, Remote Solutions Manager, and Director, Client Services.   As a member of the RCCS team Teri advises and leads clients in the areas of billing and reimbursement for technology, monitoring government regulatory information and seeking new business opportunities.    

    Teri completed her Bachelors of Arts degree at the University of Northern Iowa.  She completed her Radiologic Technology certificate at Mayo School for Health Related Sciences in Rochester, MN and her certificate for Radiation Therapy at Fairview University Medical Center in Minneapolis, MN.  She also earned her certification as a Certified Professional Coder (CPC) through the American Academy of Professional Coders (AAPC). 

    Teri is active in the ARRT, ASRT, and AAPC.  She lectures and participates at national seminars in conjunction with the AAPC, ACCC, ACRO, and ASRT.  

    Ron DiGiaimo, MBA, FACHE

    CEO, Revenue Cycle Coding Strategies

    As CEO, Ron leads Revenue Cycle Inc. with more than 27 years in clinical, mid-level and executive level management, clinical experience and financial management. He is also a proven strategist in practice building, coding and documentation for both Part A and Part B reimbursement and has broad experience with marketing, operations, development and public relations.

    Ron is active with ACRO, ASTRO, SROA, ACCC, ACE, AAMD, ASCO, ACHE and several other groups whose missions forward the cause of oncology. He currently assists with the publication of the American College of Radiation Oncology Practice Management Guide, which serves to educate the oncology community as a whole.

    Ron earned an MBA from Oklahoma Christian University a bachelor of science in health services administration from Weber State University, Utah and an associate's degree in radiography from MCC in Waco, Texas. His clinical and strong operational management experience assist in both short and long term goal achievement for hospitals and providers alike.

    Dan Sherman, MA, LPC

    Financial Navigator/Consultant, The NaVectis Group

    Dan E. Sherman, MA, LPC, has been in the field of financial navigation services for oncology patients since 2008, and is the founder and president of the NaVectis Group, a consulting company that assists oncology providers in the implementation of financial navigation programs. In 2009, he created and implemented the Financial Navigation Program at the Lacks Cancer Center, and has since been recognized by the Oncology Roundtable, Access Management, and the Association of Community Cancer Centers’ Oncology Issues for his expertise in clinical financial navigation. He has also been published in the Journal of Access Management, ACCC’s Oncology Issues journal, the American Journal of Managed Care, and ASCO’s Journal of Oncology Practice. 
    Dan has a degree in accounting, psychology, and a master’s in counseling.

    I can't login or view sessions. What do I do? 

    First, make sure you are using Chrome, Firefox, or Microsoft Edge. The system does not work with Internet Explorer. Then, check to verify that you are logged in.

    How do I access the sessions?

    You can access any of the sessions by clicking on the “Sessions” tab.

    From there, select the session you would like to view. Click on the title and you will see a button to the right of the session title. If the session will begin in the next 15 minutes, the button will say "Early Event Login is Open". If the session has started, it will say "Live Event in Progress". If you do not see one of those buttons, you may need to refresh your screen, especially if you log in more than 15 minutes before the session starts. 

    I am having audio trouble. How can I fix that?

    If you are not able to hear any audio through your computer speakers first check to make sure your speakers are not muted or turned off.  

    The next step is to refresh your screen by pressing the F5 key on your keyboard or clicking the “refresh” button in your web browser. 

    For technical issues, including slides that are not loading, please read the following.

    Please ensure your organization meets hardware, software and bandwidth requirements well in advance 

    Step 1: Browser Tests

    Please take the following browser test: https://zoom.us/test

    Step 2: Please review the following Technical Requirements and be sure your system and networks are up to date.

    Minimum System Requirements:

    2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended) Minimum Browser Requirements:  

    Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/  

    Windows 7 or later Mac OS X 10.9 or later Chrome 60 or greater Firefox 52 or greater Edge 14  or greater Safari 10 or greater iOS 10 or greater Internet Explorer 11 IP Addresses and Ports to Allow for HTML5:   72.32.161.112 port 80, 443 (web and audio) 72.32.200.104 port 80, 443 (web and audio) 72.32.221.65 ports 80, 443 (web and audio) 72.32.221.66 ports 80, 443 (web and audio) 67.203.7.114 ports 80, 443 (web and audio)

    Other Recommendations: It is recommended that you use a PC or MAC with an updated Internet Browser. Make sure you have pop-ups blockers disabled in your Internet browser settings. Make sure that your internet browser is Active X enabled. Wifi is not recommended. The problem with WiFi is signal strength can vary causing bandwidth to increase or decrease. We recommend a wired connection. A wired connection gives a consistent signal and consistent bandwidth. A wired connection provides a better experience. Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers  so you can hear the presenters.

    Still having issues? Please email registration@accc-cancer.org

  • ACCC 37th National Oncology Conference [On-Demand]

    Contains 11 Product(s)

    The leading conference for innovation in cancer care delivery is now available on-demand! Participation in the enduring activities of the ACCC 37th [Virtual] National Oncology Conference will be available for 12 months and will award continuing education hours for physicians, nurses, pharmacists, and administrators as appropriate.

    image

    The leading conference for innovation in cancer care delivery is now available on-demand!

    Discover the convenience of viewing the ACCC 37th [Virtual] National Oncology Conference (#ACCCNOC) content from your home or office.

    If you registered for the virtual conference in September, on-demand access is included in your registration. You can revisit the sessions for a deeper dive or catch the presentations you didn’t have time to watch. 

    Participation in the enduring activities of the ACCC 37th National Oncology Conference will be available for 12 months and will award continuing education hours for physicians, nurses, pharmacists, and administrators as appropriate.

    If you haven’t registered yet, it’s not too late!  Click the green Register button in the upper right corner of this page to purchase the #ACCCNOC on-demand content package.

    Registration Type

    Registration Fee

    ACCC Member 

    ACCC Cancer Program Members, Individual Provider Members,
    ACCC Individual Consultants, Industry Members,
    and members of the Oncology State Societies at ACCC

    $100.00

    Non-member Provider & Industry

    Individuals who are employed by a cancer program, practice, non-profit organization,
    consulting company, pharmaceutical/device manufacturer,
    diagnostic testing company, or technology/analytics company

    $300.00

     

    ACCC Industry Advisory, Emerging Companies, and Technical Advisory Council Members and employees of sponsor companies of the ACCC 37th [Virtual] National Oncology Conference are entitled to a free registration. If you are not yet registered, please contact Mike Andrews, Senior Director, Corporate Relations or Don Cooksey, Senior Manager, Exhibit Sales & Corporate Relations for further assistance.

    #ACCCNOC On-Demand Highlights:

    • Learn from your device where it’s convenient for you—watch presentations on your computer, tablet, or smartphone
    • Relive the conference experience with presentation slides with synchronized audio and video
    • Access more than 10 hours of breakout sessions and keynote presentations
    • Learn on your schedule with 24/7 online access
    • Personalize your #ACCCNOC On-Demand learning experience by tailoring your professional development to your own interests—on your own time.

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing this content. 

     If you have any questions or feedback, please feel free to email us.

    #ACCCNOC On-Demand allows you to watch and re-watch sessions on your own time, with a better ability to: 
    • Review leadership strategies to enhance resilience among teams and organizations in response to adversities and to review strategies to improve the quality of cancer care 
    • Integrate innovative approaches for onboarding experienced non-oncology nurses to address staffing shortages 
    • Use targeted management algorithms to identify patient co-morbidities aiming to reduce hospital and emergency department admissions 
    • Discuss the benefits of creating and implementing a collaborative pharmacist practice agreement to improve oral oncolytic workflow and reduce treatment delays
    • Explore the use of a 3D-printed lung nodule educational tool to help providers educate patients, reduce distress, and engage in shared decision-making 
    • Outline approaches to implement a nurse navigator-led community-based cardio-oncology clinic to manage cardio-toxic side effects in oncology patients and improve patient quality of life 
    • Identify clinical variables associated with increased risk of hospital and emergency department admissions using predictive modeling and proactively manage patients to reduce readmissions after chemotherapy 
    • Adapt a transition plan to administer chemotherapy in the outpatient setting to improve care, lower infection rates, improve quality of life, and reduce cost of care 
    • Investigate the role of prehab, rehab, and prospective surveillance in improving patient experience, reducing hospital stay, early identification of physical impairments, functional limitations, and/or treatment restrictions, and in palliative care for patients with advanced cancer 
    • Examine strategies to address the disparities faced by women in oncology 

    Participation in the enduring activities of the ACCC 37th National Oncology Conference (#ACCCNOC) will be available for 12 months and will award continuing education hours for physicians, nurses, pharmacists, and administrators as appropriate.

    The breakdown of accreditation(s) per session and hour(s) offered are as follow: 

     

    Accreditation (s) Offered

    Title 

    CME 

    CPE 

    CNE 

    ACHE-Q 

    Onboarding Experienced Non-Oncology Nurses to Address Staffing Shortages: Development of a Transitional Oncology Training Academy 

    0.5 

    0.5 

    Utilizing Technology to Identify Patient Co-Morbidities and Reduce Hospital and ED Admissions 

    1.25 

    1.25 

    Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement 

    1.25 

    1.25 

    1.25 

    1.25 

    Leveraging a 3D Lung Nodule Educational Tool to Reduce Patient Distress 

    A Nurse Navigator-Led Community-Based Cardio-Oncology Clinic 

    1.25 

    Reducing Readmissions after Chemotherapy with Predictive Modeling of Risk Factors 

    1.25 

    1.25 

    1.25 

    Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs 

    1.25 

    1.25 

    1.25 

    1.25 

    Integration of Prehab, Rehab, and Prospective Surveillance into Interdisciplinary Teams 

    1.25 

    1.25 

    Total Hours 

    3.75 

    2.5 

    8.0 

    6.75 

  • Acute Lymphocytic Leukemia: Critical Insights

    Contains 4 Component(s)

    Using a case-based approach, experts discuss current treatment strategies for Ph(+) and Ph(-) patients, and take a closer look at the role of minimal residual disease (MRD) for prognosis and treatment selection.

    Hear critical insights from multidisciplinary cancer team members with expertise in treating older adolescents and adults with acute lymphocytic leukemia (ALL). Using a case-based approach, these experts discuss current treatment strategies for Ph(+) and Ph(-) patients, and take a closer look at the role of minimal residual disease (MRD) for prognosis and treatment selection. Special attention is paid to identification and management of cytokine release syndrome (CRS), along with pertinent drug-drug interactions when using Bcr-Abl tyrosine kinase inhibitors (TKIs) as part of combination treatment. If you have any questions along the way please contact  Monique Dawkins, Assistant Director, Provider Education for ACCC.

  • Acute Lymphocytic Leukemia: Supporting the Patient Journey

    Contains 4 Component(s)

    Listen to perspectives on how to effectively support patients diagnosed with acute lymphocytic leukemia (ALL) throughout the care journey from multidisciplinary cancer team members and a patient representative.

    Listen to perspectives on how to effectively support patients diagnosed with acute lymphocytic leukemia (ALL) throughout the care journey from multidisciplinary cancer team members and a patient representative. Panelists define cohesive communication between the care team and the patient, describe elements required to deliver compassionate care and introduce cost awareness, and discuss how to present treatment risk-benefit analysis. If you have any questions along the way please contact Monique Dawkins, Assistant Director, Provider Education for ACCC.

  • Alternative Payment Models in Cancer Care eLearning Modules

    Contains 15 Component(s)

    A seven-part e-module series covering each domain of an APM Readiness Assessment to help you determine the next steps for your cancer center when implementing APMs.

    You must have an ACCC account in order to register for this course.

    If You DO NOT Have An ACCC Account:

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
      • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
      • OSS at ACCC Members: Please use your state society login credentials.
      • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

    If You Have An ACCC Account:

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
    • You will be automatically redirected back to this course, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    As a result of market pressures to expand value-based healthcare in oncology, the Association of Community Cancer Centers (ACCC) developed the Alternative Payment Model Coalition (APMC) to gain important insights into how APMs impact cancer delivery. The APMC focuses primarily on providing education about APMs and other value-based programs in cancer care.

    This seven-part e-module builds on the Oncology APM Readiness Assessment first introduced during the APMC workshop. If your cancer center is ready to begin or expand its journey to value-based care—but you are not sure how to get started—these modules can help. In each session, we will dive deeper into each domain and help you determine what is next for your cancer center. We will outline specific next steps and action items your organization can take to begin APM program implementation. In addition, we will also provide real-life examples that correspond to each topic.
    Although all seven modules work together, we intentionally designed them so you can view each module independently in short bursts, as they are each 15 to 20 minutes long.

    The e-modules will address:
    •How to evaluate market feasibility.
    •What entails a comprehensive provider network.
    •The key components of care delivery transformation.
    •How robust technology can support your value-based care delivery models.
    •The types of effective payment models that define value-based payments.
    •How to align provider compensation.
    •Why a strong organizational foundation is essential

    The ACCC Alternative Payment Model Coalition is supported by Amgen, Merck & Co, Inc., and Takeda.

    Purvi Bhatt, MBA

    ECG Management Consultants

    Purvi is highly regarded for her practical knowledge of reimbursement strategies and her track record of executing managed care contracting plans that result in significant revenue enhancements. A valued member of ECG's Contracting and Reimbursement practice, for 10 years Purvi has provided extensive executive-level leadership to physician groups, hospitals and health systems in the area of payor contracting, where an organization's portfolio of commercial contracts is critical to revenue viability. She has helped clients optimize their payor portfolios, achieving top-line revenue gains of 10% to 20%. Her clients appreciate her ability to understand the critical, financial, operational, and other business terms that typically affect contract performance.  

    Purvi also works closely with providers and health systems as they transition from volume- to value-based delivery systems, analyzing quality and financial data; facilitating stakeholder discussions regarding a culture of collaboration, creativity, and accountability; and developing accountable care organization/delivery-based strategies.

    Valerie Csik, BS

    Director, Quality and Care Transformation Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System

    Valerie Csik, MPH, CPPS is the Director of Quality and Care Transformation for the cancer service line at Thomas Jefferson University Health System. She oversees oncology quality initiatives in the Sidney Kimmel Cancer Center, and her responsibilities include managing the cancer center’s participation in the Centers for Medicare and Medicaid Services (CMS) Oncology Care Model program, as well as aligning various shared savings programs and quality initiatives to improve operations and reduce care variation.  

     Since 2005, Csik has been a dedicated volunteer with the American Cancer Society. She has held various leadership positions, serves as the Chair of the Greater Philadelphia Volunteer Leadership Council, and was the Founding Chair of the Young Professionals of the American Cancer SocietyPhiladelphia Chapter 

    Csik started her career at Thomas Jefferson University and then joined the Patient Safety Organization partnering with healthcare systems around the world to evaluate and improve patient safety culture. Valerie returned to Jefferson as Project Director in the department of medical oncology. Her education includes a bachelor’s degree in Healthcare Administration from the University of Scranton and masters degree in Public Health from Thomas Jefferson University. She is also a graduate of the American Hospital Association (AHA) and National Patient Safety Foundation (NPSF) Comprehensive Patient Safety Leadership Fellowship and is a Certified Professional of Patient Safety. 

    Anne Marie Rainey

    MSN, RN, CHC

    Anne Marie Rainey, RN, MSN, CHC, is the Compliance and Quality Control Officer at Clearview Cancer Institute in Huntsville, Alabama. She has previous experience in government quality reporting as a contractor for the Centers for Medicare Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC)

    After obtaining her Master of Nursing in Clinical Leadership and Administration, Rainey transitioned to the community oncology setting. Her work interests include quality metrics analysis, program implementation, health policy, and advocacy for community oncology.  

    Amy Ellis

    Chief Quality Officer, Northwest Medical Specialties, PLLC (NWMS)

    Amy Ellis is the director of Quality and Value Based Care at Northwest Medical Specialties, PLLC (NWMS). In this role, she oversees NWMS strategic practice initiatives and value-based care programs including the Oncology Care Model, Oncology Medical Home and various commercial payment models. Ms. Ellis works to continually transform the way care is provided to patients by utilizing innovative tools such as artificial intelligence, care management technology, population health technology, continual process improvement, and data analysis. 

    She brings 14 years of healthcare experience, including outpatient radiology and clinical oncology research. Amy has been recognized for her work on the Payment Reform Committee of the Community Oncology Alliance (COA), her active involvement in the Association of Community Cancer Centers (ACCC) Conference Planning Task Force and practice initiatives, as well as her value-based care leadership with the Quality Cancer Care Alliance Network and Washington state oncology initiatives. She is passionate about the quality of care provided to patients and strives to improve outcomes and the patient experience. 

    In 2019, Amy received a HemOnc Today’s Next Gen Innovator award for her forward-thinking approach in cancer care.

    Mark Liu

    Director, Strategic Initiatives, Mount Sinai Health System

    Mark Liu is the Director of Strategic Initiatives for the oncology service line at the Mount Sinai Health Systeman eight-hospital integrated health system in all five boroughs of New York City. He works closely with senior leadership to develop long-term strategy, while collaborating to drive critical projects to completion.   

    He first joined Mount Sinai as part of a team to facilitate the build of Mount Sinai Health Partners, a new entity advancing population health within the health system. Prior to >span class="TextRun SCXW202804268 BCX9" xml:lang="EN-US" lang="EN-US">Liu managed ambulatory care operations at Memorial Sloan Kettering Cancer Center across nine different solid and hematologic cancers during his eight-year tenure. 
     
    He received a Bachelor of Science, double majoring in Integrated Neuroscience and Sociology, from Binghamton University.  Liu was selected as a 2008 fellow for the New York University (NYU) Leadership Initiative and NYU Wagner Fellowship for Emerging Leaders in Public Service. He is currently completing his Master of Healthcare Administration at the Mailman School of Public Health at Columbia University.

    Jordan Brozyna, BBA

    ECG Management Consultants

    Jordan’s diverse background in managed care work gives her a unique perspective in delivering results to clients. Utilizing her strong analytics skills, Jordan is able to convey thoughtful, data-driven solutions for both traditional contracting engagements and progressive value-based care initiatives. Through her experience, Jordan has developed a deep understanding of the nuances of healthcare industry as she has worked with hospitals, physician groups, and ambulatory surgical centers. Specifically, she has established expertise in the development and implementation of alternative payment models (APMs). She is passionate about payment reform, new delivery models, and the healthcare system of the future. Jordan will work to ensure your organization is on the right path to success.

    Summary of Expertise

    Since joining ECG over five years ago, Jordan has worked with several health systems to develop, implement, and maintain bundled payment programs. Specifically, she supports hospital and physician leadership in care process redesign and care coordination improvement. Additionally, Jordan has expertise in bundled payment pricing analytics, especially for providers wishing to pursue commercial or employer-based bundles. Recently, Jordan worked with a health system to achieve more than $5 million in savings over three years through the implementation of a bundled payment initiative.

    Jordan is also regarded for her work with clients to optimize their payer portfolios and develop reimbursement strategies. Partnering with provider groups, she works side-by-side with physicians and administrators to help them increase revenue and foster stronger payer relationships. Recently, Jordan helped a pediatrics practice achieve a 10% revenue increase across their top commercial payers.  Furthermore, as the healthcare industry experiences a significant shift from inpatient to ambulatory care, Jordan has worked with ASCs to help them bring new and unique services to market. Specifically, she works with payers to help them understand the value of these novel procedures and, as a result, establish reimbursement for the ASCs.


  • A Review of Validated Tools for Geriatric Assessment and How to Use Them

    Contains 2 Component(s) Recorded On: 05/13/2019

    Join in a practical review of validated geriatric assessment tools and learn how to incorporate them into your oncology practice. Logistics, including who can and should administer the assessment will also be included.

    Join in a practical review of validated geriatric assessment tools and learn how to incorporate them into your oncology practice. Logistics, including who can and should administer the assessment will also be included. 

    Faculty: 

    Tanya Wildes, MD, MSCI
    Assistant Professor, Department of Medicine, Oncology Division, Washington University School of Medicine
    St. Louis, Missouri

  • ASCO Survey on COVID-19 in Oncology (ASCO) Registry

    Contains 3 Component(s)

    ACCC COVID-19 Webinar

    Join the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO) for a webcast on how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research.

    Hear how the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) is collecting information about patterns of symptoms and severity of COVID-19 infection, the influences on the delivery of cancer care, and decision-making for future disease outbreaks.

    Dr. Richard L. Schilsky, ASCO’s Chief Medical Officer and Executive Vice President, will discuss the critical need to capture and analyze this longitudinal data, review the data collection process, and outline future registry deliverables.

    Dr. Randall A. Oyer, Medical Director, Oncology Program, Penn Medicine Lancaster General Health, and ACCC President, will discuss his experience as a participating practice in the ASCO Registry and how his program intends to use the data.

    As part of the 2020-2021 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research, ACCC is exploring the impact of COVID-19 on all facets of cancer care, including the administration of—and patient access to—clinical trials. Learn how participating in the ASCO Registry will support this work.

    Randall Oyer, MD

    Medical Director, Oncology Program, Penn Medicine Lancaster General Health and ACCC President

    Randall A. Oyer, MD, is a practicing medical oncologist at the Ann B. Barshinger Cancer Institute at Penn Medicine Lancaster General in Lancaster, Pennsylvania. He serves as the Medical Director of the Cancer Institute, Medical Director of Oncology, Chairman of Cancer Committee, Chair of the Oncology Physicians Advisory Council, and Medical Director of the Cancer Risk Evaluation (Cancer Genetics) Program at Penn Medicine Lancaster General. Dr. Oyer is a member of the Cancer Service Line Executive Committee and the Cancer Service Line Quality Committee at the Abramson Cancer Center─University of Pennsylvania, Philadelphia.

    Dr. Oyer divides his time among patient care, program administration, program development, and community outreach. He works closely with a multidisciplinary team that comprises nursing, social work, pharmacy, chaplaincy, and medical specialties focused on strategy, implementation, and patient care. A long-standing active member of the Association of Community Cancer Centers (ACCC), Dr. Oyer is currently serving on the Board of Trustees. He is also an ex-officio Commissioner of the American College of Surgeons Commission on Cancer, representing the ACCC.

    Dr. Oyer is serving co-chair of the Advisory Committee for the ACCC Optimal Care Coordination Model for Lung Cancer Patients on Medicaid education project. He is an active member of the ACCC Governmental Affairs Committee, participating in Capitol Hill visits and advocating on behalf of community cancer care. Previously, Dr. Oyer served as an Advisory Committee member for the ACCC Molecular Testing education project, and he has presented a several ACCC meetings.

    In addition to his participation in ACCC, he has served as a member of the Centers for Medicare & Medicaid Services (CMS) Ambulatory Payment Classification Panel and of the American Society of Clinical Oncology (ASCO) Clinical Practice Committee.

    Dr. Oyer is a graduate of Georgetown University and Georgetown University School of Medicine.

    Richard Schilsky, MD

    ASCO Chief Medical Officer and Executive Vice President

    Dr. Schilsky is the Chief Medical Officer (CMO) and Executive Vice President of ASCO. Formerly the Chief of Hematology/Oncology in the Department of Medicine and Deputy Director of the University of Chicago Comprehensive Cancer Center, he is a highly respected leader in the field of clinical oncology. He specializes in new drug development and treatment of gastrointestinal cancers. Dr. Schilsky is a Past President of ASCO, having served in the role during 2008-2009, and is also a Past Chair of one of the National Cancer Institute’s Cooperative Groups, Cancer and Leukemia Group B (CALGB).

    Dr. Schilsky’s impressive experience and many accomplishments in both clinical medicine and clinical research reflect his deep passion for cancer medicine. He has spent the majority of his career at the University of Chicago, where he joined the faculty in 1984, subsequently rising to the rank of Professor of Medicine and serving in many roles, including Associate Dean for Clinical Research in the Biological Sciences Division and Director of the University of Chicago Cancer Research Center.

    From 1995 to 2010, Dr. Schilsky served as Chair of the Cancer and Leukemia Group B (CALGB), a national cooperative clinical research group funded by the National Cancer Institute (NCI). He has extensive experience working with both the NCI and the Food and Drug Administration (FDA) having served as a member and chair of the NCI Board of Scientific Advisors, as a member of the NCI Clinical and Translational Research Committee, and as a member and chair of the Oncologic Drugs Advisory Committee of the FDA. Dr. Schilsky has served on the editorial boards of many cancer journals, including the Journal of Clinical Oncology. He presently serves on the editorial board of the New England Journal of Medicine.

    Early in his career, he worked in the Clinical Pharmacology Branch of the Division of Cancer Treatment at the NCI and was an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Missouri-Columbia School of Medicine. He was also the head of the hematology/medical oncology unit at the Harry S. Truman Veterans’ Administration Hospital in Columbia, Missouri.

  • BiomarkerLive

    Contains 9 Component(s)

    Introduction to cancer biomarkers, relevant terminology, and implications for cancer care.

    This webinar series covers the foundational elements of biomarker testing and application in cancer care. Topics include biomarker basics, inherited cancers, cost and coverage, laboratory medicine and tumor-specific case examples. 

    The ACCC BiomarkerLIVE project is supported by AbbVie, Lilly Oncology, and Merck & Co., Inc. 

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webcast.

    You must have an ACCC account in order to register for this webinar series.

    If You DO NOT Have An Account:

    • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
      • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
      • OSS at ACCC Members: Please use your state society login credentials.
      • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
    • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
    • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

    If You Have An Account:

    • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
    • You will be automatically redirected back to this webinar series page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

    PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

    For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

    Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar series. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

    Patricia Friend, PhD, APRN-CNS, AOCNS, AGN-BC

    Associate Professor and Program Director Marcella Niehoff School of Nursing Loyola University Chicago

    Patricia Friend, PhD, APRN-CNS, AOCNS, AGN-BC, has advanced certification in oncology nursing and is board-certified in advanced genetics nursing. Her areas of expertise are in oncology and genomics, educational preparation of advanced practice nurses, online education, and interprofessional education and practice. Her doctoral dissertation work was supported by the American Cancer Society (doctoral scholarship) and a pre-doctoral fellowship (F31) from the National Cancer Institute. Her doctoral research, examining the interactions between stress and immune responses in women undergoing diagnostic breast biopsy, was funded by the National Cancer Institute, the Oncology Nursing Foundation, and the Chicago Chapter of the Oncology Nursing Society. Additionally, Dr. Friend has experience with educational training grants and currently leads a team of faculty supported by the NCI-sponsored Interprofessional Education Exchange (iPEX) Project, that is developing interprofessional education in palliative care.

    Dr. Friend’s main area of clinical scholarship and research interest is in the area of genetics/genomics. She serves on the Genomics Advisory Board for the Oncology Nursing Society and is interested in improving genomic literacy of healthcare educators, students, and clinicians.

    Sue Friedman, DVM

    Executive Director and Founder, Facing Our Risk of Cancer Empowered (FORCE)

    Dr. Sue Friedman was practicing small animal medicine in south Florida in 1996 when she was diagnosed "out of the blue" at age 33 with breast cancer. At the time, she was unaware of familial risk factors for hereditary cancer. Reading an article about hereditary breast cancer after completing her treatment, Sue realized that she had several indications for a mutation. She pursued genetic counseling and, in 1997, tested positive for a BRCA2 mutation.

    Shocked that her health care team didn't alert her to the possibility of being at high risk, and disappointed at having to make critical treatment decisions while unaware of her mutation, Sue acted so others could benefit from her misfortune. She founded FORCE in 1999 to fill the information void for individuals and families with hereditary cancer and to help them advocate for themselves. After five years as the organization's executive director (while maintaining her own busy practice), Sue left veterinary medicine to direct FORCE full-time. Since then, the organization has become an unequaled source of research, advocacy, support, and information regarding risk management, prevention, and awareness.

    In 2004, Sue relocated her husband Dan, son Beau, and FORCE headquarters to Tampa to work more closely with researchers to improve medical options, care, and outcomes for people affected by hereditary cancer. She is a 20-year breast cancer survivor.

    Sue is co-author of the book Confronting Hereditary Breast and Ovarian Cancer, which was published by Johns Hopkins Press, February 2012.

    Sarah Hamilton, MS, CGC

    Genetic Counselor, Rocky Mountain Cancer Centers – Boulder

    Sarah Hamilton is a certified genetic counselor with over seven years of experience. Sarah began her career as a clinical genetic counselor in Christchurch, New Zealand and worked in a hereditary gastrointestinal cancer clinic. During that time, she developed expertise in the management of Lynch Syndrome and polyposis syndromes. She returned to the United States in May 2019 and is now working for Invitae on their Clinical Consultation Services team. Sarah remains particularly interested in the ever-evolving field of cancer genetics and welcomes any and all opportunities to speak about this topic to patients and clinicians.  

    Outside of her professional interests, Sarah is an avid skier, hiker, and biker and enjoys doing all of these activities near her home in Boulder, Colorado. She also loves to cook, listen to podcasts, and knit.  

  • BiomarkerLIVE: An Introduction to the Biomarker Lexicon & Resource Library

    Contains 2 Component(s)

    This webinar explores how cancer programs can use these tools, plus members of the BiomarkerLIVE Advisory Committee describe the current cancer biomarker landscape and present three case examples.

    To support the cancer care team in the integration of biomarkers into everyday practice, ACCC developed a Biomarker Lexicon and a Biomarker Resource Library. This webinar explores how cancer programs can use these tools, plus members of the BiomarkerLIVE Advisory Committee describe the  current cancer biomarker landscape and present three case examples.